Chang Woo Lee

Chang Woo Lee

Auto-generated profile, based on publicly available information

Chang Woo Lee

University Hospitals Dorset NHS Foundation Trust

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
HJHyun Ju Jung
Hyun Ju Jung
SCSuk Won Choi
Suk Won Choi
KBKyung-Hwan Boo
Kyung-Hwan Boo
JKJee-Eun Kim
Jee-Eun Kim
YOYoung Kyoung Oh
Young Kyoung Oh
SYSeong Wook Yang
Seong Wook Yang
The core plant microprocessor consists of DICER-LIKE 1 (DCL1), SERRATE (SE), and HYPONASTIC LEAVES 1 (HYL1) and plays a pivotal role in microRNA (miRNA) biogenesis. However, the proteolytic regulation of each component remains elusive. Here, we show that HYL1-CLEAVAGE SUBTILASE 1 (HCS1) is a cytoplasmic protease for HYL1-destabilization. HCS1-excessiveness reduces HYL1 that disrupts miRNA biogenesis, while HCS1-deficiency accumulates HYL1. Consistently, we identified the HYL1K154A mutant that is insensitive to the proteolytic activity of HCS1, confirming the importance of HCS1 in HYL1 proteostasis. Moreover, HCS1-activity is regulated by light/dark transition. Under light, cytoplasmic CONSTITUTIVE PHOTOMORPHOGENIC 1 (COP1) E3 ligase suppresses HCS1-activity. COP1 sterically inhibits HCS1 by obstructing HYL1 access into the catalytic sites of HCS1. In contrast, darkness unshackles HCS1-activity for HYL1-destabilization due to nuclear COP1 relocation. Overall, the COP1-HYL1-HCS1 network may integrate two essential cellular pathways: the miRNA-biogenetic pathway and light signaling pathway. Significance HYPONASTIC LEAVES 1 (HYL1)-CLEAVAGE SUBTILASE 1 (HCS1) is a novel negative regulator of microRNA (miRNA) biogenesis that degrades HYL1 in the cytoplasm. Furthermore, cytoplasm CONSTITUTIVE PHOTOMORPHOGENIC 1 (COP1) E3 ligase inhibit HCS1-mediated HYL1 degradation. The COP1-HYL1-HCS1 network may integrate two essential cellular pathways: the miRNA-biogenetic pathway and light signaling pathway. Our finding suggests a regulatory pathway in the miRNA-biogenetic system.

2 December 2021 in Cureus
Verified
Journal Article
Open access
AMAngelos Mantelakis
Angelos Mantelakis
GLGeorge Lafford
George Lafford
CLChang Woo Lee
Chang Woo Lee
HSHarry Spencer
Harry Spencer
JDJean-Luc Deval
Jean-Luc Deval
AJAnil Joshi
Anil Joshi
First described by Polish Neurologist Łucja Frey in 1923, Frey’s syndrome (FS), or auriculotemporal syndrome, is a rare condition characterised by gustatory sweating, typically encountered as sequelae following invasive head and neck surgery. The pathophysiology of FS can be described by aberrant reinnervation of postganglionic parasympathetic neurons to the surrounding denervated sweat glands and cutaneous blood vessels. Multiple invasive procedures have been associated with FS ranging from salivary gland surgery to burn reconstruction and thoracoscopic sympathectomies. Rarely, FS can be secondary to trauma or non-surgical aetiologies, including diabetes and infection. Physical symptoms vary based on the severity and surface area affected by FS and range from mild symptoms to severe psychosocial morbidity for patients. Surgeons operating in the head and neck, including otolaryngologists, maxillofacial surgeons, and plastic surgeons, should be aware of this potential complication and be up to date with diagnosis and treatment strategies for FS. This review article summarises the literature relating to FS focusing on its aetiologies, symptomatology, prevention, and available treatments, aiming to provide an up-to-date review of this condition for surgeons operating in the head and neck region. Although various treatment options have been suggested, these are often limited to topical agents that require life-long administration for symptom control. Further research is recommended to identify the optimal treatment for this condition and the role of surgery as a treatment for severe or refractory cases.

1 January 2004 in Journal of Veterinary Science
Verified
Journal Article
Open access
SRSeung Ho Ryu
Seung Ho Ryu
UBUng Bok Bak
Ung Bok Bak
CLChang Woo Lee
Chang Woo Lee
YLYonghoon Lyon Lee
Yonghoon Lyon Lee
A 13-year-old Thoroughbred mare, retired from race, was admitted to Equine Hospital, Korea Racing Association with signs of colic. One and a half months following the previous treatment (second time) and 11 days following her previous discharge (third time), the mare repeatedly exhibited signs of colic and finally along with icteric eyes. Routine medical treatment with intravenous fluids, analgesics resulted in resolution of signs of colic in the first and second admission. The condition of the mare did not improve in the third admission despite over one month supportive treatment and she was subject to euthanasia at the request of the owner on the thirtyeighth day of hospitalization (95 days from her first admission). The clinical signs (fever, icterus, mild intermittent colic) in conjunction with clinical laboratory findings (leukocytosis, elevations of serum total bilirubin, direct bilirubin, alkaline phosphatase, aspartate aminotransferase, gamma glutamyl transferase, creatine phosphokinase, lactic dehydrogenase and blood fibrinogen indicative of obstructive biliary disease) in this mare suggested possible chlolelithiasis. However, liver enzymes and bilirubin estimations are often not part of routine screening in emergency colic cases. At necropsy, multiple dark brown choleliths of various sizes obstructing hepatopancreatic ampulla were found in the hepatic duct. The choleliths were found as large as 3-5 cm in diameter, faceted to each other, dark brown in color and showed soap consistency. Histopathologic findings revealed: biliary fibrosis, plugging of the bile canaliculi with bile pigments, cholangiohepatitis and pigmentation of the hepatic lymph node with bile pigment laden macrophages. Although definitive diagnosis of cholelithiasis might be challenging, clinicians should consider this condition in the differential diagnosis of recurrent colic.

12 August 2024 in Journal of Voice
Verified
Journal Article
Closed access
CLChang Woo Lee
Chang Woo Lee
MKMarie T. Krüger
Marie T. Krüger
HAHarith Akram
Harith Akram
LZLudvic Zrinzo
Ludvic Zrinzo
JRJohn Rubin
John Rubin
JFJonathan M. Fishman
Jonathan M. Fishman

1 January 2003 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
CLChang Woo Lee
Chang Woo Lee
HBHoil Bang
Hoil Bang
YOYeon Gyun Oh
Yeon Gyun Oh
HYHyang Suk Yun
Hyang Suk Yun
JKJong Duck Kim
Jong Duck Kim
CCChang Jun Coe
Chang Jun Coe
Lee CW, et al. Yonsei Med J. 2003 Apr;44(2):331-335. http://dx.doi.org/10.3349/ymj.2003.44.2.331

26 February 2022 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
CLChang Woo Lee
Chang Woo Lee
SDSophie Dupré
Sophie Dupré
FMFergal Marlborough
Fergal Marlborough
MIMuhammad Shahid Iqbal
Muhammad Shahid Iqbal
CKCharles Kelly
Charles Kelly
DSDaniel B. Saleh
Daniel B. Saleh